Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0A0SI
|
||||
Former ID |
DNCL003393
|
||||
Drug Name |
BAY 85-8501
|
||||
Indication | Bronchiectasis [ICD9: 494, 748.61; ICD10:J47, Q33.4] | Phase 2 | [549458] | ||
Company |
Bayer HealthCare Pharmaceuticals
|
||||
Structure |
Download2D MOL |
||||
Target and Pathway | |||||
Target(s) | Leukocyte elastase | Target Info | Modulator | [533269] | |
Pathway Interaction Database | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling | ||||
C-MYB transcription factor network | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.